Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 114,701 | 0 | 0 | 0 | 0 |
| Gross Profit | 114,701 | N/A | N/A | N/A | N/A |
| Operating Expenses | 174,620 | 183,759 | 218,593 | 216,124 | 233,962 |
| Operating Income | -59,919 | -183,759 | -218,593 | -216,124 | -233,962 |
| Interest Expense | 11,517 | 13,511 | 13,880 | 19,440 | 12,666 |
| Other Income | 15,801 | 17,453 | 3,095 | 1,560 | 3,268 |
| Pre-tax Income | -55,635 | -179,817 | -229,378 | -234,004 | -243,360 |
| Income Tax | 893 | 0 | 0 | N/A | N/A |
| Net Income Continuous | -56,528 | -179,817 | -229,378 | -234,004 | -243,360 |
| Net Income | $-56,528 | $-179,817 | $-229,378 | $-234,004 | $-243,360 |
| EPS Basic Total Ops | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| EPS Basic Continuous Ops | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| EPS Diluted Total Ops | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| EPS Diluted Continuous Ops | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 |
| EBITDA(a) | $-67,744 | $-187,503 | $-214,406 | $-203,887 | $-225,739 |